Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1985 1
1986 3
1988 1
1990 1
1992 1
1997 2
1998 1
1999 1
2000 6
2001 4
2002 4
2003 3
2004 5
2005 3
2006 2
2007 4
2008 10
2009 1
2010 6
2011 9
2012 7
2013 5
2014 8
2015 7
2016 5
2017 8
2018 10
2019 14
2020 6
2021 6
2022 11
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Craig TJ, Reshef A, Li HH, Jacobs JS, Bernstein JA, Farkas H, Yang WH, Stroes ESG, Ohsawa I, Tachdjian R, Manning ME, Lumry WR, Saguer IM, Aygören-Pürsün E, Ritchie B, Sussman GL, Anderson J, Kawahata K, Suzuki Y, Staubach P, Treudler R, Feuersenger H, Glassman F, Jacobs I, Magerl M. Craig TJ, et al. Among authors: kawahata k. Lancet. 2023 Apr 1;401(10382):1079-1090. doi: 10.1016/S0140-6736(23)00350-1. Epub 2023 Feb 28. Lancet. 2023. PMID: 36868261 Clinical Trial.
Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies.
Kamiya M, Mizoguchi F, Kawahata K, Wang D, Nishibori M, Day J, Louis C, Wicks IP, Kohsaka H, Yasuda S. Kamiya M, et al. Among authors: kawahata k. Nat Commun. 2022 Jan 10;13(1):166. doi: 10.1038/s41467-021-27875-4. Nat Commun. 2022. PMID: 35013338 Free PMC article.
Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments.
Kawahata K, Ishii T, Gono T, Tsuchiya Y, Ohashi H, Yoshizawa K, Zheng R, Ayabe M, Nishikawa K. Kawahata K, et al. RMD Open. 2023 Aug;9(3):e003268. doi: 10.1136/rmdopen-2023-003268. RMD Open. 2023. PMID: 37652554 Free PMC article. Clinical Trial.
Age-associated CD4+ T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity.
Goto M, Takahashi H, Yoshida R, Itamiya T, Nakano M, Nagafuchi Y, Harada H, Shimizu T, Maeda M, Kubota A, Toda T, Hatano H, Sugimori Y, Kawahata K, Yamamoto K, Shoda H, Ishigaki K, Ota M, Okamura T, Fujio K. Goto M, et al. Among authors: kawahata k. Sci Immunol. 2024 Mar 29;9(93):eadk1643. doi: 10.1126/sciimmunol.adk1643. Epub 2024 Mar 29. Sci Immunol. 2024. PMID: 38330141
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, Shiraki M, Ohnishi H, Yasumura J, Kawabe T, Miyamae T, Matsubara T, Arakawa N, Ishige T, Takizawa T, Shimbo A, Shimizu M, Kimura N, Maeda Y, Maruyama Y, Shigemura T, Furuta J, Sato S, Tanaka H, Izumikawa M, Yamamura M, Hasegawa T, Kaneko H, Nakagishi Y, Nakano N, Iida Y, Nakamura T, Wakiguchi H, Hoshina T, Kawai T, Murakami K, Akizuki S, Morinobu A, Ohmura K, Eguchi K, Sonoda M, Ishimura M, Furuno K, Kashiwado M, Mori M, Kawahata K, Hayama K, Shimoyama K, Sasaki N, Ito T, Umebayashi H, Omori T, Nakamichi S, Dohmoto T, Hasegawa Y, Kawashima H, Watanabe S, Taguchi Y, Nakaseko H, Iwata N, Kohno H, Ando T, Ito Y, Kataoka Y, Saeki T, Kaneko U, Murase A, Hattori S, Nozawa T, Nishimura K, Nakano R, Watanabe M, Yashiro M, Nakamura T, Komai T, Kato K, Honda Y, Hiejima E, Yonezawa A, Bessho K, Okada S, Ohara O, Takita J, Yasumi T, Nishikomori R; Japan CAPS Working Group. Miyamoto T, et al. Among authors: kawahata k. Arthritis Rheumatol. 2024 Jan 25. doi: 10.1002/art.42808. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38268504
Evolution of the avian digital pattern.
Kawahata K, Cordeiro IR, Ueda S, Sheng G, Moriyama Y, Nishimori C, Yu R, Koizumi M, Okabe M, Tanaka M. Kawahata K, et al. Sci Rep. 2019 Jun 12;9(1):8560. doi: 10.1038/s41598-019-44913-w. Sci Rep. 2019. PMID: 31189916 Free PMC article.
Anti-IL-10 antibody in systemic lupus erythematosus.
Uchida M, Ooka S, Goto Y, Suzuki K, Fujimoto H, Ishimori K, Matsushita H, Takakuwa Y, Kawahata K. Uchida M, et al. Among authors: kawahata k. Open Access Rheumatol. 2019 Mar 26;11:61-65. doi: 10.2147/OARRR.S191953. eCollection 2019. Open Access Rheumatol. 2019. PMID: 30988645 Free PMC article.
Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study.
Fukuda T, Yamagami K, Kawahata K, Suzuki Y, Sasaki Y, Miyagi T, Jacobs I, Lawo JP, Glassman F, Akama H, Hide M, Ohsawa I. Fukuda T, et al. Among authors: kawahata k. Allergol Int. 2023 Jul;72(3):451-457. doi: 10.1016/j.alit.2023.02.002. Epub 2023 Feb 28. Allergol Int. 2023. PMID: 36858856 Free article. Clinical Trial.
Interleukin-23 as a therapeutic target for inflammatory myopathy.
Umezawa N, Kawahata K, Mizoguchi F, Kimura N, Yoshihashi-Nakazato Y, Miyasaka N, Kohsaka H. Umezawa N, et al. Among authors: kawahata k. Sci Rep. 2018 Apr 3;8(1):5498. doi: 10.1038/s41598-018-23539-4. Sci Rep. 2018. PMID: 29615652 Free PMC article.
149 results